G1 THERAPEUTICS INC's ticker is GTHX and the CUSIP is 3621LQ109. A total of 95 filers reported holding G1 THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 0.97 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $93,000 | +9.4% | 3,536 | -5.4% | 0.00% | 0.0% |
| Q3 2019 | $85,000 | -12.4% | 3,736 | +18.0% | 0.00% | 0.0% |
| Q2 2019 | $97,000 | +120.5% | 3,166 | +18.8% | 0.00% | – |
| Q1 2019 | $44,000 | -13.7% | 2,666 | 0.0% | 0.00% | – |
| Q4 2018 | $51,000 | -64.8% | 2,666 | -3.6% | 0.00% | -100.0% |
| Q3 2018 | $145,000 | +0.7% | 2,766 | -29.1% | 0.00% | 0.0% |
| Q2 2018 | $144,000 | 0.0% | 3,900 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $144,000 | +166.7% | 3,900 | +44.4% | 0.00% | 0.0% |
| Q4 2017 | $54,000 | -5.3% | 2,700 | +17.4% | 0.00% | 0.0% |
| Q3 2017 | $57,000 | – | 2,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 98,482 | $1,631,000 | 0.60% |
| Opus Point Partners Management, LLC | 20,844 | $346,000 | 0.47% |
| HHLR ADVISORS, LTD. | 949,431 | $15,761,000 | 0.44% |
| Rhenman & Partners Asset Management AB | 212,169 | $3,522,000 | 0.41% |
| Virtus ETF Advisers LLC | 8,654 | $144,000 | 0.31% |
| BB BIOTECH AG | 671,925 | $11,154,000 | 0.28% |
| RA Capital Management | 363,051 | $6,027,000 | 0.26% |
| BDO Wealth Advisors, LLC | 35,234 | $585,000 | 0.17% |
| Birchview Capital, LP | 15,000 | $249,000 | 0.16% |
| SECOR Capital Advisors, LP | 37,205 | $618,000 | 0.13% |